Irene Gil-Fariña

846 total citations · 1 hit paper
24 papers, 617 citations indexed

About

Irene Gil-Fariña is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Irene Gil-Fariña has authored 24 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 14 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Irene Gil-Fariña's work include Virus-based gene therapy research (15 papers), CRISPR and Genetic Engineering (8 papers) and CAR-T cell therapy research (7 papers). Irene Gil-Fariña is often cited by papers focused on Virus-based gene therapy research (15 papers), CRISPR and Genetic Engineering (8 papers) and CAR-T cell therapy research (7 papers). Irene Gil-Fariña collaborates with scholars based in Germany, Spain and United Kingdom. Irene Gil-Fariña's co-authors include Manfred Schmidt, Gloria González‐Aseguinolaza, Jesús Prìeto, Esperanza López‐Franco, Delia D’Avola, Alberto Benito, Harald Petry, Raffaele Fronza, Christine Kaeppel and Valérie Ferreira and has published in prestigious journals such as Blood, Nature Biotechnology and The Journal of Immunology.

In The Last Decade

Irene Gil-Fariña

24 papers receiving 605 citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evaluating the state of the science for adeno-associated virus integration: An integrated perspective

2022 128 citations Denise E. Sabatino, Frederic D. Bushman et al. Molecular Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Irene Gil-Fariña Germany	10	420	368	131	80	59	24	617
Carmencita E. Nicolas United States	2	684 1.6×	314 0.9×	133 1.0×	38 0.5×	51 0.9×	2	776
Samuele Ferrari Italy	10	616 1.5×	371 1.0×	218 1.7×	39 0.5×	95 1.6×	20	746
Nicole C. Hasbrouck United States	5	470 1.1×	550 1.5×	228 1.7×	76 0.9×	44 0.7×	8	677
Raisa Jofra Hernández Italy	12	206 0.5×	191 0.5×	172 1.3×	51 0.6×	107 1.8×	17	484
Sean Hofherr United States	14	624 1.5×	670 1.8×	228 1.7×	184 2.3×	42 0.7×	26	938
Francesca Ferrua Italy	14	248 0.6×	241 0.7×	144 1.1×	37 0.5×	167 2.8×	21	545
Bernd Schiedlmeier Germany	7	555 1.3×	506 1.4×	212 1.6×	51 0.6×	67 1.1×	8	749
Joanna Sinclair United Kingdom	9	679 1.6×	735 2.0×	392 3.0×	83 1.0×	190 3.2×	11	996
Hengjun Chao United States	11	706 1.7×	737 2.0×	318 2.4×	74 0.9×	50 0.8×	17	994
Helga Björgvinsdóttir Sweden	9	190 0.5×	188 0.5×	152 1.2×	64 0.8×	287 4.9×	16	556

Countries citing papers authored by Irene Gil-Fariña

Since Specialization

Citations

This map shows the geographic impact of Irene Gil-Fariña's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Gil-Fariña with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Gil-Fariña more than expected).

Fields of papers citing papers by Irene Gil-Fariña

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Gil-Fariña. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Gil-Fariña. The network helps show where Irene Gil-Fariña may publish in the future.

Co-authorship network of co-authors of Irene Gil-Fariña

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Gil-Fariña. A scholar is included among the top collaborators of Irene Gil-Fariña based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Gil-Fariña. Irene Gil-Fariña is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lengler, Johannes, Markus Weiller, Maria Schuster, et al.. (2025). Preclinical development of TAK-754, a high-performance AAV8-based vector expressing coagulation factor VIII. Molecular Therapy — Methods & Clinical Development. 33(1). 101424–101424. 1 indexed citations

Díaz-Pascual, Francisco, Hanem Sadek, Irene Gil-Fariña, et al.. (2024). Restoration of T and B Cell Differentiation after RAG1 Gene Transfer in Human RAG1 Defective Hematopoietic Stem Cells. Biomedicines. 12(7). 1495–1495. 3 indexed citations

Klaften, Matthias, et al.. (2024). P20 Clinical metagenomics from cell-free DNA: overview and lessons learned from 4 years as a clinical metagenomics provider. JAC-Antimicrobial Resistance. 6(Supplement_1). 1 indexed citations

Batty, Paul, Sylvia Fong, Choong‐Ryoul Sihn, et al.. (2024). Vector integration and fate in the hemophilia dog liver multiple years after AAV-FVIII gene transfer. Blood. 143(23). 2373–2385. 9 indexed citations

Zabaleta, Nerea & Irene Gil-Fariña. (2023). Tracing the fate of AAV vectors in the body. Nature Biotechnology. 42(8). 1183–1184. 1 indexed citations

Castiello, Maria Carmina, Elena Draghici, Elena Fontana, et al.. (2023). Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying Rag1 hypomorphic mutations. Frontiers in Immunology. 14. 1268620–1268620. 3 indexed citations

Payne, Annette, Susan Jobling, David C. Hay, et al.. (2022). HIV- 1 lentivirus tethering to the genome is associated with transcription factor binding sites found in genes that favour virus survival. Gene Therapy. 29(12). 720–729. 8 indexed citations

Sabatino, Denise E., Frederic D. Bushman, Randy J. Chandler, et al.. (2022). Evaluating the state of the science for adeno-associated virus integration: An integrated perspective. Molecular Therapy. 30(8). 2646–2663. 128 indexed citations breakdown →

Öztürk, Selcen, Irene Gil-Fariña, Anna Jauch, et al.. (2021). Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients. Leukemia. 36(2). 464–475. 6 indexed citations

10.

Chan, Jerry Kok Yen, Irene Gil-Fariña, Cecilia Rosales, et al.. (2018). Therapeutic expression of human clotting factors IX and × following adeno‐associated viral vector‐mediated intrauterine gene transfer in early‐gestation fetal macaques. The FASEB Journal. 33(3). 3954–3967. 25 indexed citations

11.

Wünsche, Peer, Tim Holland‐Letz, Anna Paruzynski, et al.. (2018). Mapping Active Gene-Regulatory Regions in Human Repopulating Long-Term HSCs. Cell stem cell. 23(1). 132–146.e9. 9 indexed citations

12.

Fronza, Raffaele, Daniela Cesana, Eugenio Montini, et al.. (2017). Lentiviral Vector Promoter is Decisive for Aberrant Transcript Formation. Human Gene Therapy. 28(10). 875–885. 6 indexed citations

13.

Gil-Fariña, Irene, Richard Gabriel, Shahzad Ahmad, et al.. (2017). Systematic comparative study of computational methods for T-cell receptor sequencing data analysis. Briefings in Bioinformatics. 20(1). 222–234. 13 indexed citations

14.

Mattar, Citra Nurfarah Zaini, Irene Gil-Fariña, Cecilia Rosales, et al.. (2017). In Utero Transfer of Adeno-Associated Viral Vectors Produces Long-Term Factor IX Levels in a Cynomolgus Macaque Model. Molecular Therapy. 25(8). 1843–1853. 37 indexed citations

15.

Gil-Fariña, Irene & Manfred Schmidt. (2016). Interaction of vectors and parental viruses with the host genome. Current Opinion in Virology. 21. 35–40. 13 indexed citations

16.

Gil-Fariña, Irene, Raffaele Fronza, Christine Kaeppel, et al.. (2016). Recombinant AAV Integration Is Not Associated With Hepatic Genotoxicity in Nonhuman Primates and Patients. Molecular Therapy. 24(6). 1100–1105. 134 indexed citations

17.

D’Avola, Delia, Esperanza López‐Franco, Bruno Sangro, et al.. (2016). Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria. Journal of Hepatology. 65(4). 776–783. 111 indexed citations

18.

Scala, Marianna Di, Irene Gil-Fariña, Lucía Vanrell, et al.. (2015). Chronic exposure to IFN drives medullar lymphopoiesis towards T cell differentiation in mice. Haematologica. 100(8). 1014–22. 8 indexed citations

19.

Gil-Fariña, Irene, Marianna Di Scala, Lucía Vanrell, et al.. (2013). IL12-Mediated Liver Inflammation Reduces the Formation of AAV Transcriptionally Active Forms but Has No Effect over Preexisting AAV Transgene Expression. PLoS ONE. 8(7). e67748–e67748. 18 indexed citations

20.

Vanrell, Lucía, Marianna Di Scala, Laura Blanco, et al.. (2011). Development of a Liver-specific Tet-On Inducible System for AAV Vectors and Its Application in the Treatment of Liver Cancer. Molecular Therapy. 19(7). 1245–1253. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact